Use of cardiac biomarkers to improve initiation of cardioprotective therapy in patients with breast cancer receiving cardiotoxic chemotherapy in a multidisciplinary cancer center.
Romil Patel, Poornima Saha(NorthShore University HealthSystem), Kyla Lee, Abdulrazzak Zarifa(The University of Texas MD Anderson Cancer Center), Tanvir Bajwa(Aurora Health Care), Jason Robin(Northwestern University)
Cited by 1
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832
Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair
|Journal of the American College of Cardiology|2012|567
4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
|Journal of the American College of Cardiology|2013|444